$74.99
2.63 (-3.39%)
Last updated: Apr 16, 2026 02:31
Fundamentals Overview
CVS Health Corporation is in the middle of its 52-week range with premium valuation, trending downward today.
Valuation premium
Intrinsic value (DCF)
+588.5% upside vs price
Profitability
Risk (Beta)
0.51 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +588.5% upside vs price · Analyst grade: B · Sentiment improving (2 upgrades)
Pressures (Sell):
3M vs S&P 500: -7.4%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 8, Market Perform: 4, Outperform: 7, Overweight: 11.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $516.31; current price is $74.99. That’s a +588.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 54.16 |
| DCF value (model) | $516.31 (588.5% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.27 |
| P/S (TTM) | 0.24 |
| P/FCF (TTM) | 12.22 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 0.84 |
| Quick Ratio (TTM) | 0.63 |
| Cash Ratio (TTM) | 0.1 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 0.44% |
| Gross margin (TTM) | 13.77% |
| Operating margin (TTM) | 1.16% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for CVS.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Piper Sandler | maintain | Overweight | Overweight | 2026-03-31 |
| Bernstein | upgrade | Market Perform | Outperform | 2026-03-12 |
| Argus Research | maintain | Buy | Buy | 2026-01-28 |
| B of A Securities | maintain | Buy | Buy | 2026-01-27 |
| Bernstein | maintain | Market Perform | Market Perform | 2026-01-06 |
| JP Morgan | maintain | Overweight | Overweight | 2025-12-17 |
| Bernstein | maintain | Market Perform | Market Perform | 2025-12-12 |
| Truist Securities | maintain | Buy | Buy | 2025-12-10 |
| Barclays | maintain | Overweight | Overweight | 2025-12-10 |
| UBS | maintain | Buy | Buy | 2025-12-10 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-12-10 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-12-10 |
| Mizuho | maintain | Outperform | Outperform | 2025-12-10 |
| Baird | maintain | Outperform | Outperform | 2025-12-10 |
| Bernstein | maintain | Market Perform | Market Perform | 2025-12-05 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-11-13 |
| TD Cowen | maintain | Buy | Buy | 2025-11-03 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-10-30 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-10-30 |
| Truist Securities | maintain | Buy | Buy | 2025-10-30 |
| RBC Capital | maintain | Outperform | Outperform | 2025-10-30 |
| UBS | maintain | Buy | Buy | 2025-10-24 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-10-14 |
| Mizuho | maintain | Outperform | Outperform | 2025-10-09 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-10-07 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-09-22 |
| Bernstein | maintain | Market Perform | Market Perform | 2025-09-05 |
| Barclays | maintain | Overweight | Overweight | 2025-09-04 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2025-08-26 |
| UBS | upgrade | Neutral | Buy | 2025-08-18 |